Physician profile
Neal S Elattrache
NPI 1669457354
$50,973,415.13
in general payments reported to CMS, 2019-2025
11 companies · $5.3M in 2025
The $5.3M reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8.0M · 2020: $7.7M · 2021: $8.3M · 2022: $7.1M · 2023: $7.8M · 2024: $6.8M · 2025: $5.3M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $20M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $3,457 · Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,933,120.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,750.00 |
| Travel and Lodging | $3,457.46 |
| Food and Beverage | $3,185.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $50,964,520.04 | 2019-2025 | Arthrex, Spine Instruments Endoscopic Instrument Sets, Shoulder Implants |
| Micromed INC | $7,081.08 | 2020-2022 | |
| Smith+Nephew, INC. | $658.70 | 2019-2025 | N/A, Cap-Fix, Acufex |
| Stryker Corporation | $527.34 | 2020-2023 | |
| Goode Surgical INC | $249.02 | 2023 | |
| Depuy Synthes Sales INC. | $132.76 | 2019-2022 | |
| Pylant Medical | $130.98 | 2022 | |
| Saxum Surgical, INC. | $52.92 | 2023 | |
| Maruho Medical, INC. | $47.40 | 2021 | |
| Dynasplint Systems INC. | $14.89 | 2025 | Dynasplint |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$160,645.42 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Elattrache listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.